Home The Word Brain	My Amedeo FAQ Privacy About
	2049 Chinese The 20K Word Road to Mandarin Proficiency By B. S. Kamps et al.

HIV Infection

Free Subscription 02.09.2024 9 AIDS 4 Clin Infect Dis 6 HIV Med 1 J Acquir Immune Defic Syndr 8 J Infect Dis 2 J Med Virol 1 J Virol 1 Lancet 4 Lancet Infect Dis 1 N Engl J Med 1 Nat Med 1 Nat Ment Health 1 Nature 15 PLoS One 2 Proc Natl Acad Sci U S A 2 Vaccine

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

AIDS

1. TARAMASSO L, Dentone C, Cama I, Fenoglio D, et al
   Distinct features of immune activation and exhaustion markers in people with perinatally-acquired HIV.
   AIDS. 2024 Aug 30. doi: 10.1097/QAD.0000000000004001.
   PubMed         Abstract available
   
   
2. NEARY J, Chebet D, Benki-Nugent S, Moraa H, et al
   Association between HIV and cytomegalovirus and neurocognitive outcomes among children with HIV.
   AIDS. 2024 Aug 29. doi: 10.1097/QAD.0000000000004000.
   PubMed         Abstract available
   
   
3. SIREGAR T, Weriditi RK, Reba YA, Muttaqin MZ, et al
   Impact of COVID-19 vaccination on HIV parameters in people with HIV on antiretroviral therapy.
   AIDS. 2024;38:1807-1808.
   PubMed        
   
   
4. CLEMENTE T, Pontillo D, Malagnino V, Calza L, et al
   Cancer in people with multidrug-resistant HIV.
   AIDS. 2024;38:1801-1806.
   PubMed         Abstract available
   
   
5. LEAL M, Kerr L, Mota RMS, Motta-Castro ARC, et al
   Increasing HIV prevalence rate among men who have sex with men: results of a comparison of two national surveys.
   AIDS. 2024;38:1799-1801.
   PubMed         Abstract available
   
   
6. GOUVEA-E-SILVA LF
   Challenges in clinical monitoring of people with HIV: evolution from prediabetes mellitus to diabetes mellitus.
   AIDS. 2024;38:1796-1798.
   PubMed        
   
   
7. NICOL MR, Dawood H, Hoy JF
   Deconvoluting the contribution of antiretroviral choice in weight gain.
   AIDS. 2024;38:1794-1795.
   PubMed        
   
   
8. CRAWFORD TN, Neilands TB, Drumright LN, Fredericksen RJ, et al
   Internalized HIV stigma and viral suppression: examining the mediating and moderating roles of substance use and social support.
   AIDS. 2024 Aug 29. doi: 10.1097/QAD.0000000000003999.
   PubMed         Abstract available
   
   
9. HYBEL TE, Sorensen EF, Enemark MH, Hemmingsen JK, et al
   Characterization of the genomic landscape of HIV-associated lymphoma reveals heterogeneity across histological subtypes.
   AIDS. 2024 Aug 22. doi: 10.1097/QAD.0000000000003996.
   PubMed         Abstract available
   
   

   
   Clin Infect Dis

10. GROENENDIJK AL, Miranda Afonso P, Wit F, Blaauw MJT, et al
    The risk of non-AIDS defining events is lower in ART-naive HIV controllers than in normal progressors on suppressive ART.
    Clin Infect Dis. 2024 Aug 29:ciae440. doi: 10.1093.
    PubMed         Abstract available
    
    
11. OGBUAGU O, Molina JM, Chetchotisakd P, Ramgopal MN, et al
    Efficacy and Safety of Long-Acting Subcutaneous Lenacapavir in Heavily Treatment-Experienced People with Multi-Drug Resistant HIV-1: Week 104 Results of a Phase 2/3 Trial.
    Clin Infect Dis. 2024 Aug 29:ciae423. doi: 10.1093.
    PubMed         Abstract available
    
    
12. BOSMAN S, Ayakaka I, Muhairwe J, Kamele M, et al
    Evaluation of C-Reactive Protein and Computer-Aided Analysis of Chest X-rays as Tuberculosis Triage Tests at Health Facilities in Lesotho and South Africa.
    Clin Infect Dis. 2024 Aug 27:ciae378. doi: 10.1093.
    PubMed         Abstract available
    
    
13. GAKURU J, Kagimu E, Dai B, Okurut S, et al
    Implementation of single high-dose liposomal amphotericin B based induction therapy for treatment of HIV-associated cryptococcal meningitis in Uganda: a comparative prospective cohort study.
    Clin Infect Dis. 2024 Aug 24:ciae413. doi: 10.1093.
    PubMed         Abstract available
    
    

    
    HIV Med

14. VASHISHT S, Thakur N, Kant S, Rai S, et al
    Assessment of targeted intervention programme under the National AIDS Control Program among men who have sex with men in India.
    HIV Med. 2024 Aug 25. doi: 10.1111/hiv.13702.
    PubMed         Abstract available
    
    
15. GRINSPOON SK, Lu MT, Zanni MV, Diggs MR, et al
    What have we learned from the REPRIEVE trial and where do we go from here?
    HIV Med. 2024 Aug 25. doi: 10.1111/hiv.13703.
    PubMed        
    
    
16. HSU RK, Brunet L, Lackey PC, Pierone G Jr, et al
    Immunological and virological response to fostemsavir in routine US clinical care: An OPERA cohort study.
    HIV Med. 2024 Aug 25. doi: 10.1111/hiv.13700.
    PubMed         Abstract available
    
    
17. LI N, Thomas L, Allan A, John B, et al
    Optimizing statin prescriptions for people living with HIV: Evidence for improved communication and shared care between primary care and specialist HIV services.
    HIV Med. 2024 Aug 26. doi: 10.1111/hiv.13704.
    PubMed         Abstract available
    
    
18. KO S, Dominguez-Dominguez L, Ottaway Z, Campbell L, et al
    Cardiovascular disease risk in people of African ancestry with HIV in the United Kingdom.
    HIV Med. 2024 Aug 29. doi: 10.1111/hiv.13706.
    PubMed         Abstract available
    
    
19. URSENBACH A, Sireyjol A, Delpierre C, Duvivier C, et al
    Increased incidence of diabetes in people living with HIV treated with first-line integrase strand transfer inhibitors: A French multicentre retrospective study.
    HIV Med. 2024 Aug 28. doi: 10.1111/hiv.13698.
    PubMed         Abstract available
    
    

    
    J Acquir Immune Defic Syndr

20. WALTERS MK, Korenromp EL, Yakusik A, Wanyeki I, et al
    Guidance for triangulating data and estimates of HIV prevalence among pregnant women and coverage of PMTCT using the Spectrum AIDS Impact Module.
    J Acquir Immune Defic Syndr. 2024 Aug 27. doi: 10.1097/QAI.0000000000003514.
    PubMed         Abstract available
    
    

    
    J Infect Dis

21. YE J, Lan Y, Wang J, Feng Y, et al
    Improvement in the 95-95-95 Targets Is Accompanied by a Reduction in Both the Human Immunodeficiency Virus Transmission Rate and Incidence in China.
    J Infect Dis. 2024 Aug 26:jiae302. doi: 10.1093.
    PubMed         Abstract available
    
    
22. YE J, Dong Y, Lan Y, Chen J, et al
    Trends and Patterns of HIV Transmitted Drug Resistance in China From 2018 to 2023.
    J Infect Dis. 2024 Aug 27:jiae303. doi: 10.1093.
    PubMed         Abstract available
    
    
23. PATEL D, Mulatu MS, Wang G, May AC, et al
    CDC-Funded HIV Testing Services Outcomes in Ending the HIV Epidemic in the U.S. (EHE) and Non-EHE Jurisdictions, 2021.
    J Infect Dis. 2024 Aug 28:jiae430. doi: 10.1093.
    PubMed         Abstract available
    
    
24. CHAIMONGKOL N, Kim DY, Matsushima Y, Durkee-Shock J, et al
    A Decade of Chronic Norovirus Infection Surveillance at the NIH Clinical Research Center: Clinical Characteristics, Molecular Epidemiology, and Replication.
    J Infect Dis. 2024 Aug 29:jiae440. doi: 10.1093.
    PubMed         Abstract available
    
    
25. AN M, Zheng C, Chen L, Li H, et al
    Sustained Spread of HIV-1 CRF55_01B in Its Place of Initial Origin: Dynamics and Hotspots.
    J Infect Dis. 2024 Aug 29:jiae428. doi: 10.1093.
    PubMed         Abstract available
    
    
26. OKAFOR EC, Mukaremera L, Hullsiek KH, Engen N, et al
    CSF Cytokines and Chemokines Involved in Cytotoxic Cell Function and Risk of Acute 14-Day Mortality in Persons with Advanced HIV and Cryptococcal Meningitis.
    J Infect Dis. 2024 Aug 28:jiae421. doi: 10.1093.
    PubMed         Abstract available
    
    
27. SERRANO-VILLAR S, Gala A, Bacchetti P, Hoh R, et al
    Galectin-9 Levels as a Potential Predictor of Intact HIV Reservoir Decay.
    J Infect Dis. 2024 Aug 28:jiae426. doi: 10.1093.
    PubMed         Abstract available
    
    
28. SERRANO-RISQUEZ C, Omar M, Rallon N, Benito JM, et al
    Impact of HLA allele-KIR partners on sexually transmitted HIV-1 infection.
    J Infect Dis. 2024 Aug 29:jiae436. doi: 10.1093.
    PubMed         Abstract available
    
    

    
    J Med Virol

29. PASSERINI S, Fracella M, Benvenuto D, Bugani G, et al
    High rates of anal Merkel Cell Polyomavirus and HPV co-infection among people living with HIV.
    J Med Virol. 2024;96:e29883.
    PubMed         Abstract available
    
    
30. FOURY A, Saunier A, Taverniers A, Pinet N, et al
    The relevance of ultradeep sequencing for low HIV-1 viral loads and proviruses in the clinical setting.
    J Med Virol. 2024;96:e29870.
    PubMed         Abstract available
    
    

    
    J Virol

31. BRACKENRIDGE S, John N, He W, Fruh K, et al
    Regulation of the cell surface expression of classical and non-classical MHC proteins by the human cytomegalovirus UL40 and rhesus cytomegalovirus Rh67 proteins.
    J Virol. 2024 Aug 29:e0120624. doi: 10.1128/jvi.01206.
    PubMed         Abstract available
    
    

    
    Lancet

32. BASSEY AE
    The health of migrants at the intersection of mpox and HIV.
    Lancet. 2024 Aug 23:S0140-6736(24)01753-7. doi: 10.1016/S0140-6736(24)01753.
    PubMed        
    
    

    
    Lancet Infect Dis

33. HOLT E
    Setbacks and advances in the global HIV response.
    Lancet Infect Dis. 2024;24:e554.
    PubMed        
    
    
34. VANBAELEN T, Manoharan-Basil SS, Kenyon C
    Studies of post-exposure prophylaxis with doxycycline should consider population-level selection for antimicrobial resistance.
    Lancet Infect Dis. 2024 Aug 21:S1473-3099(24)00502.
    PubMed        
    
    
35. STARBUCK E
    Biopolitical precarity for women with HIV in South Africa.
    Lancet Infect Dis. 2024 Aug 26:S1473-3099(24)00572.
    PubMed        
    
    
36. PANNIKOTTU J, Reuter A, Pietersen E, Makhanda G, et al
    Waiting is no longer an option for household contacts of people with drug-resistant tuberculosis.
    Lancet Infect Dis. 2024;24:947-949.
    PubMed        
    
    

    
    N Engl J Med

37. NACHEGA JB, Mohr EL, Dashraath P, Mbala-Kingebeni P, et al
    Mpox in Pregnancy - Risks, Vertical Transmission, Prevention, and Treatment.
    N Engl J Med. 2024 Aug 28. doi: 10.1056/NEJMp2410045.
    PubMed        
    
    

    
    Nat Med

38. HEMONO R, Gatare E, Kayitesi L, Hunter LA, et al
    Effect of a digital school-based intervention on adolescent family planning and reproductive health in Rwanda: a cluster-randomized trial.
    Nat Med. 2024 Aug 23. doi: 10.1038/s41591-024-03205.
    PubMed         Abstract available
    
    

    
    Nat Ment Health

39. GRELOTTI DJ, Montoya J, Delorme-Walker V, Iudicello J, et al
    On the issue of treating HIV in people with syndemic mental-health and substance-use disorders.
    Nat Ment Health. 2024;2:879-880.
    PubMed         Abstract available
    
    

    
    Nature

40. RYU JK, Yan Z, Montano M, Sozmen EG, et al
    Fibrin drives thromboinflammation and neuropathology in COVID-19.
    Nature. 2024 Aug 28. doi: 10.1038/s41586-024-07873.
    PubMed         Abstract available
    
    

    
    PLoS One

41. AVENANT C, Singata-Madliki M, Bick AJ, Africander D, et al
    The injectable contraceptives depot medroxyprogesterone acetate and norethisterone enanthate substantially and differentially decrease testosterone and sex hormone binding globulin levels: A secondary study from the WHICH randomized clinical trial.
    PLoS One. 2024;19:e0307736.
    PubMed         Abstract available
    
    
42. CHAMA GC, Siame L, Kapoma C, Hamooya BM, et al
    Severe acute malnutrition among children under the age of 5 years.
    PLoS One. 2024;19:e0309122.
    PubMed         Abstract available
    
    
43. GUERRERO-TAMAYO A, Sanz Urquijo B, Olivares I, Moragues Tosantos MD, et al
    Classification of SARS-CoV-2 sequences as recombinants via a pre-trained CNN and identification of a mathematical signature relative to recombinant feature at Spike, via interpretability.
    PLoS One. 2024;19:e0309391.
    PubMed         Abstract available
    
    
44. OGOLA B, Matume ND, Tebit DM, Mavhandu-Ramarumo LG, et al
    Immunologic, virologic and drug resistance outcomes in an HIV-infected prospective cohort on treatment in South Africa.
    PLoS One. 2024;19:e0307519.
    PubMed         Abstract available
    
    
45. KAMVUMA K, Masenga S, Hamooya B, Chanda W, et al
    Prevalence and factors associated with moderate-to-severe anaemia among virally suppressed people with HIV at a tertiary hospital in Zambia.
    PLoS One. 2024;19:e0303734.
    PubMed         Abstract available
    
    
46. ASSEFA M, Amare A, Tigabie M, Girmay G, et al
    Burden of multidrug-resistant bacteria among HIV-positive individuals in Ethiopia: A systematic review and meta-analysis.
    PLoS One. 2024;19:e0309418.
    PubMed         Abstract available
    
    
47. NAWATTANAPAIBOOL N, Ruang-Areerate T, Piyaraj P, Leelayoova S, et al
    Development of nucleic acid lateral flow immunoassay for duplex detection of Leishmania martiniquensis and Leishmania orientalis in asymptomatic patients with HIV.
    PLoS One. 2024;19:e0307601.
    PubMed         Abstract available
    
    
48. TOROKAA PR, Majigo MV, Kileo H, Urio L, et al
    The pattern of rpoB gene mutation of Mycobacterium tuberculosis and predictors of rifampicin resistance detected by GeneXpert MTB/RIF assay in Tanzania.
    PLoS One. 2024;19:e0296563.
    PubMed         Abstract available
    
    
49. GUURE C, Dery S, Baptista da Silva C, Asamoah-Adu C, et al
    Situational assessment and epidemiology of HIV, HBV and HCV among people who use and inject drugs in Ghana.
    PLoS One. 2024;19:e0305923.
    PubMed         Abstract available
    
    
50. SINGOGO E, Hartney T, Bourdin S, Chagomerana M, et al
    Use of routinely collected blood donation data for expanded HIV and Syphilis surveillance in Blantyre district, Malawi.
    PLoS One. 2024;19:e0300647.
    PubMed         Abstract available
    
    
51. MOLLEL GJ, Ketang'enyi E, Komba L, Mmbaga BT, et al
    Study protocol for Sauti ya Vijana (The Voice of Youth): A hybrid-type 1 randomized trial to evaluate effectiveness and implementation of a mental health and life skills intervention to improve health outcomes for Tanzanian youth living with HIV.
    PLoS One. 2024;19:e0305471.
    PubMed         Abstract available
    
    
52. NJAU T, Sunguya B, Mwakawanga DL, Minja A, et al
    The unmet mental health needs of adolescents with HIV in eastern Tanzania: Experiences of healthcare providers, adolescents, and caregivers.
    PLoS One. 2024;19:e0307143.
    PubMed         Abstract available
    
    
53. FELDACKER C, Klabbers RE, Huwa J, Kiruthu-Kamamia C, et al
    The effect of proactive, interactive, two-way texting on 12-month retention in antiretroviral therapy: Findings from a quasi-experimental study in Lilongwe, Malawi.
    PLoS One. 2024;19:e0298494.
    PubMed         Abstract available
    
    
54. ATUJUNA M, Williams K, Roberts ST, Young A, et al
    We choose: Adolescent girls and young women's choice for an HIV prevention product in a cross-over randomized clinical trial conducted in South Africa, Uganda, and Zimbabwe.
    PLoS One. 2024;19:e0308577.
    PubMed         Abstract available
    
    
55. MFIPA D, Hajison PL, Mpachika-Mfipa F
    Predictors of low birthweight and comparisons of newborn birthweights among different groups of maternal factors at Rev. John Chilembwe Hospital in Phalombe district, Malawi: A retrospective record review.
    PLoS One. 2024;19:e0291585.
    PubMed         Abstract available
    
    

    
    Proc Natl Acad Sci U S A

56. CAPOFERRI AA, Wiegand A, Hong F, Jacobs JL, et al
    HIV-1 control in vivo is related to the number but not the fraction of infected cells with viral unspliced RNA.
    Proc Natl Acad Sci U S A. 2024;121:e2405210121.
    PubMed         Abstract available
    
    
57. MEHTA K, Yentsch H, Lee J, Yook Y, et al
    Phosphatidylinositol-3-phosphate mediates Arc capsid secretion through the multivesicular body pathway.
    Proc Natl Acad Sci U S A. 2024;121:e2322422121.
    PubMed         Abstract available
    
    

    
    Vaccine

58. NAVARRO-TORNE A, Anderson A, Panwar K, Ghys E, et al
    How has post-implementation surveillance of high-coverage vaccination with HPV16/18-AS04 vaccine in England added to evidence about its cross-protective effects?
    Vaccine. 2024;42:126215.
    PubMed         Abstract available
    
    
59. GUZMAN RUIZ L, Zollner AM, Hoxie I, Kuchler J, et al
    Enhancing NA immunogenicity through novel VLP designs.
    Vaccine. 2024;42:126270.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO HIV Infection is free of charge.